Zydus gets tentative USFDA approval for Dexamethasone Tablets USP, 1 mg
Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
ANDAs
Masterclass with Masihuddin Jaigirdar, Pharmaceutics Expert | Session 1 | Regulatory Watch
The world of pharma regulations is constantly evolving, presenting new challenges and opportunities. In this ever-changing…
Masterclass with Masihuddin Jaigirdar, Pharmaceutics Expert | Session 2 | Regulatory Watch
The world of pharma regulations is constantly evolving, presenting new challenges and opportunities. In this ever-changing…
Masterclass with Masihuddin Jaigirdar, Pharmaceutics Expert | Session 3 | Regulatory Watch
The world of pharma regulations is constantly evolving, presenting new challenges and opportunities. In this ever-changing…
Zydus gets USFDA approval for Roflumilast Tablets, 250 mcg
Roflumilast reduces inflammation in the lungs that leads to chronic obstructive pulmonary disease (COPD)
Zydus gets tentative nod from USFDA for Gabapentin Tablets, 300 mg and 600 mg
Gabapentin tablets are indicated for the management of Postherpetic Neuralgia (PHN)
Strides Pharma Science to acquire Endo’s manufacturing facility in US
Strides said the facility at Chestnut Ridge, New York has an annual capacity of two billion units across semi-solids, liquids and…
Glenmark Pharma gets tentative nod from US FDA for acne treatment drug
The drug, Clindamycin Phosphate Foam, 1 per cent, is a generic version of Mylan Pharmaceuticals' Evoclin Foam
FDA publishes draft guidance on assessing adhesion with TDS and topical patches for ANDAs
Updated recommendations are provided for the statistical analysis of adhesion scores and results
The FDA has published the draft…